Targeting Errant Immune System Enzyme Kills Myelodysplastic Cells
Scientists have successfully targeted a malfunctioning immune system enzyme to kill diseased cells from patients with myelodysplastic syndrome (MDS) - a blood disorder and precursor to leukemia. Reporting their results July 8 in Cancer Cell, researchers say their successful laboratory tests in human MDS cells and mouse models of MDS provide a molecular target for designing new drugs to battle a syndrome with few effective treatments...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Health | Laboratory Medicine | Leukemia | Myelodysplastic Syndrome | Vaccines